The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression
Research output: Contribution to journal › Journal article › Research › peer-review
The aim of this study was to determine whether there is a protective effect of combination antiretroviral therapy (cART) on the development of clinical events in patients with ongoing severe immunosuppression.
| Original language | English |
|---|---|
| Journal | Antiviral Therapy |
| Volume | 17 |
| Issue number | 7 |
| Pages (from-to) | 1291-300 |
| Number of pages | 10 |
| DOIs | |
| Publication status | Published - 2012 |
- Acquired Immunodeficiency Syndrome, Adult, CD4 Lymphocyte Count, Drug Evaluation, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Protease Inhibitors, HIV-1, Humans, Immunocompromised Host, Incidence, Male, Middle Aged, Poisson Distribution, Prospective Studies, Reverse Transcriptase Inhibitors, Risk Factors, Viral Load, Viremia
Research areas
ID: 105612276